different cryptocurrencies Top

The liquor sector moved up, Tianyoude Liquor rose daily, Gujing Distillery rose by more than 4%, and Huangtai Liquor, Shunxin Agriculture, Laobaigan Liquor and Yilite followed suit.Rifa Seiki: Xunmi Technology went to the company to investigate and discuss products such as end-horizontal machining center and thread grinder. On December 11th, Xunmi Technology co-president Lei Ming and his party visited and investigated Seiki Seiki in Japan. Chasing technology has visited the production workshop of Maichuang and bearing equipment in depth, and gained an in-depth understanding of the specific situation of products such as high-end horizontal machining center and thread grinder of Nissan Seiki from research and development to production. Not only that, the two sides also conducted in-depth exchanges and discussions on the intelligent production line structure, core components, product accuracy and related issues in the practical application of a complete set of solutions. According to the data, Chasing Technology began to lay out robots in 2021, and successively launched bionic quadruped robot dogs, universal humanoid robots and other products. In September this year, Xunmi Technology released X50 series sweeping robots, equipped with the world's first "bionic mechanical foot obstacle-crossing technology".Trump said that he chose Kari Lake as the director of VOA.

Zhangjiakou Smart Grid Auto Equity Investment Fund was registered and established. The enterprise search APP shows that recently, Zhangjiakou Smart Grid Auto Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 301 million yuan. Its business scope includes: engaging in equity investment, investment management and asset management with private equity funds. Enterprise investigation shows that the company is jointly owned by Zhangjiakou Industrial Investment Holding Group Co., Ltd. and Zhangjiakou Nanshan Economic Development Zone Construction and Development Co., Ltd.PETER LAMELAS was nominated by Trump as the US ambassador to Argentina.Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.

Nearly 40% of the skilled talents in Shenzhen exceed 4 million, and the total number of skilled talents in Shenzhen now reaches 4.033 million, and the proportion of skilled talents has increased to 38.5%. The team size and the proportion of skilled talents are among the highest in the country ... From the launching ceremony of the 4th Shenzhen Craftsman Week and the summary meeting of skilled talents in 2024 held recently, it was learned that the construction of high-skilled talents in Shenzhen achieved positive results in 2024, which became an important foundation for supporting Shenzhen's manufacturing and Shenzhen's innovation. (Shenzhen Special Zone Daily)The retail sector rose and strengthened, and more than 10 stocks such as Yonghui Supermarket rose and strengthened. More than 10 stocks such as Yonghui Supermarket, Maoye Commercial, Zhongbai Group, Nanning Department Store, Youhao Group and Dongbai Group rose and strengthened.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.